Literature DB >> 33646129

Using a Tablet-Based App to Deliver Evidence-Based Practices for Suicidal Patients in the Emergency Department: Pilot Randomized Controlled Trial.

Linda A Dimeff1, David A Jobes2, Kelly Koerner1, Nadia Kako1, Topher Jerome1, Angela Kelley-Brimer1, Edwin D Boudreaux3, Blair Beadnell4, Paul Goering5, Suzanne Witterholt5, Gabrielle Melin6, Vicki Samike6, Kathryn M Schak6.   

Abstract

BACKGROUND: Emergency departments (EDs) have the potential to provide evidence-based practices for suicide prevention to patients who are acutely suicidal. However, few EDs have adequate time and personnel resources to deliver recommended evidence-based assessment and interventions. To raise the clinical standard of care for patients who are suicidal and seeking psychiatric crisis services in the ED, we developed Jaspr Health, a tablet-based app for direct use by such patients, which enables the delivery of 4 evidence-based practices.
OBJECTIVE: This study aims to evaluate the feasibility, acceptability, and effectiveness of Jaspr Health among suicidal adults in EDs.
METHODS: Patients who were acutely suicidal and seeking psychiatric crisis services participated in an unblinded pilot randomized controlled trial while in the ED. Participants were randomly assigned to Jaspr Health (n=14) or care as usual (control; n=17) groups. Participants were assessed at baseline, and a 2-hour posttest using self-report measures and a semistructured interview were conducted.
RESULTS: Conditions differed significantly at baseline with regard to age but not other demographic variables or baseline measures. On average, participants had been in the ED for 17 hours before enrolling in the study. Over their lifetime, 84% (26/31) of the sample had made a suicide attempt (mean 3.4, SD 6.4) and 61% (19/31) had engaged in nonsuicidal self-injurious behaviors, with an average rate of 8.8 times in the past 3 months. All established feasibility and acceptability criteria were met: no adverse events occurred, participants' app use was high, Jaspr Health app user satisfaction ratings were high, and all participants using Jaspr Health recommended its use for other suicidal ED patients. Comparisons between study conditions provide preliminary support for the effectiveness of the app: participants using Jaspr Health reported a statistically significant increase in receiving 4 evidence-based suicide prevention interventions and overall satisfaction ratings with their ED experience. In addition, significant decreases in distress and agitation, along with significant increases in learning to cope more effectively with current and future suicidal thoughts, were observed among participants using Jaspr Health compared with those receiving care as usual.
CONCLUSIONS: Even with limited statistical power, the results showed that Jaspr Health is feasible, acceptable, and clinically effective for use by ED patients who are acutely suicidal and seeking ED-based psychiatric crisis services. TRIAL REGISTRATION: ClinicalTrials.gov NCT03584386; https://clinicaltrials.gov/ct2/show/NCT03584386. ©Linda A Dimeff, David A Jobes, Kelly Koerner, Nadia Kako, Topher Jerome, Angela Kelley-Brimer, Edwin D Boudreaux, Blair Beadnell, Paul Goering, Suzanne Witterholt, Gabrielle Melin, Vicki Samike, Kathryn M Schak. Originally published in JMIR Mental Health (http://mental.jmir.org), 01.03.2021.

Entities:  

Keywords:  digital technology; emergency department; suicide; suicide prevention

Year:  2021        PMID: 33646129      PMCID: PMC7961404          DOI: 10.2196/23022

Source DB:  PubMed          Journal:  JMIR Ment Health        ISSN: 2368-7959


  30 in total

1.  Attendance at the accident and emergency department in the year before suicide: retrospective study.

Authors:  Isaura Gairin; Allan House; David Owens
Journal:  Br J Psychiatry       Date:  2003-07       Impact factor: 9.319

Review 2.  Use of dialectical behavior therapy in inpatient treatment of borderline personality disorder: a systematic review.

Authors:  Jill Myerow Bloom; Eva N Woodward; Teresa Susmaras; David W Pantalone
Journal:  Psychiatr Serv       Date:  2012-09-01       Impact factor: 3.084

Review 3.  Cognitive-behavioral interventions to reduce suicide behavior: a systematic review and meta-analysis.

Authors:  Nicholas Tarrier; Katherine Taylor; Patricia Gooding
Journal:  Behav Modif       Date:  2008-01

4.  Emergency departments are underutilized sites for suicide prevention.

Authors:  Gregory Luke Larkin; Annette L Beautrais
Journal:  Crisis       Date:  2010

5.  Analysis of Emergency Department Length of Stay for Mental Health Patients at Ten Massachusetts Emergency Departments.

Authors:  Mark D Pearlmutter; Kristin H Dwyer; Laura G Burke; Niels Rathlev; Louise Maranda; Greg Volturo
Journal:  Ann Emerg Med       Date:  2017-01-04       Impact factor: 5.721

Review 6.  The use of dialectical behavior therapy skills training as stand-alone treatment: a systematic review of the treatment outcome literature.

Authors:  Sarah E Valentine; Sarah M Bankoff; Renée M Poulin; Esther B Reidler; David W Pantalone
Journal:  J Clin Psychol       Date:  2014-07-14

7.  The Emergency Department: Challenges and Opportunities for Suicide Prevention.

Authors:  Joan Rosenbaum Asarnow; Kalina Babeva; Elizabeth Horstmann
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2017-10

Review 8.  Managing Suicidal Patients in the Emergency Department.

Authors:  Marian E Betz; Edwin D Boudreaux
Journal:  Ann Emerg Med       Date:  2015-10-09       Impact factor: 5.721

9.  Pilot randomized clinical trial of the Teachable Moment Brief Intervention for hospitalized suicide attempt survivors.

Authors:  Stephen S O'Connor; Michael M Mcclay; Shujah Choudhry; Angela D Shields; Richard Carlson; Yaima Alonso; Kyle Lavin; Lisa Venanzi; Katherine Anne Comtois; Jo Ellen Wilson; Stephen E Nicolson
Journal:  Gen Hosp Psychiatry       Date:  2018-08-10       Impact factor: 3.238

10.  The impact of psychiatric patient boarding in emergency departments.

Authors:  B A Nicks; D M Manthey
Journal:  Emerg Med Int       Date:  2012-07-22       Impact factor: 1.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.